Company Overview
Balboa Research, operating as Balboa Research SMO+, is a well-established subsidiary of Balboa Nephrology. Formerly known as the California Institute of Renal Research, the company is located in La Jolla, California, with additional facilities across San Diego and Imperial Counties. Specializing in nephrology, Balboa Research conducts advanced clinical research in collaboration with pharmaceutical and medical device sponsors. The organization consists of 12 Principal Investigators and employs 23 dedicated research staff, operating six fully-equipped research sites to support its endeavors in renal research.
Core Areas of Focus
Balboa Research is committed to advancing healthcare solutions through its robust engagement in clinical trials and observational studies, primarily targeting therapeutic developments and diagnostics for kidney diseases. The company aims to provide comprehensive care solutions from dialysis to kidney transplants, with strong affiliations and collaborations with leading healthcare and research entities, ensuring the advancement of nephrology.
Leadership Team
The leadership at Balboa Research is driven by an experienced team comprising:
- Glenn Davis, Chief Operating Officer: Joined in June 2019, bringing a wealth of experience in healthcare management and organizational growth.
- George Nilsson, Clinical Research Director: Part of the team since 2005 and director since 2022, Nilsson oversees research projects and has extensive expertise in planning and executing clinical trials.
- Diego De Silva, Clinical Trials Manager: Responsible for operational management of the trial portfolio, De Silva ensures efficacy and compliance across research initiatives.
Facilities
Balboa Research operates a network of six research sites all equipped with state-of-the-art infrastructure vital for advanced clinical research and trials. The central office is located at 4275 Executive Square, Suite 800, La Jolla, CA 92037, providing a command center for its extensive research operations.
Research and Capabilities
With a history of conducting over 500 studies with nearly 100 sponsors, Balboa Research excels in offering high-quality Good Clinical Practice (GCP) studies. The organization specializes in navigating Phases 1B-4 trials, managing the Investigational New Drug (IND) processes, Investigational Device Exemption (IDE), and Pre-market Approval (PMA) paths. Their facilities and expertise continually propel innovation at the crossroads of the pharmaceutical and medical device sectors.
Strategic Alliances and Performance
Strategic collaborations with pharmaceutical and medical device sponsors are pivotal to Balboa Research's operations. These alliances enable early innovation and advanced testing of therapeutics and diagnostics, reflecting the organization's commitment to adaptability and excellence in clinical trials and research methodologies. Balboa Research's nearly two decades of expertise and industry positioning underscore its role as a pivotal player in nephrology research services.
Key Competitors
Within the competitive landscape, Balboa Nephrology faces notable competition from prominent health and clinical research organizations:
- American Renal Associates
- Complete Renal Care
- DaVita Kidney Care
- Mid-Atlantic Nephrology Associates, P.A.
- South Texas Renal Care Group
- Dialysis Clinic, Inc.
Contact Information
For further inquiries or collaboration opportunities, Balboa Research can be contacted at (858) 810-8000 or via email at info@bnmg.org.
Balboa Research's integrated operations within the greater Balboa Nephrology Medical Group emphasize its strategic role in healthcare research and solution delivery, focusing on the advancement of renal care through its extensive research and clinical trials framework.
